Sosnik A - Search Results

1

New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery.

Sosnik A, Carcaboso AM, Glisoni RJ, Moretton MA, Chiappetta DA. Sosnik A, et al. Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):547-59. doi: 10.1016/j.addr.2009.11.023. Epub 2009 Nov 13. Adv Drug Deliv Rev. 2010. PMID: 19914315 Review.

2

Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs.

Chiappetta DA, Sosnik A. Chiappetta DA, et al. Among authors: sosnik a. Eur J Pharm Biopharm. 2007 Jun;66(3):303-17. doi: 10.1016/j.ejpb.2007.03.022. Epub 2007 Mar 31. Eur J Pharm Biopharm. 2007. PMID: 17481869 Review.

3

Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead.

Sosnik A, Chiappetta DA, Carcaboso AM. Sosnik A, et al. J Control Release. 2009 Aug 19;138(1):2-15. doi: 10.1016/j.jconrel.2009.05.007. Epub 2009 May 13. J Control Release. 2009. PMID: 19445981 Review.

4

Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles.

Moretton MA, Glisoni RJ, Chiappetta DA, Sosnik A. Moretton MA, et al. Among authors: sosnik a. Colloids Surf B Biointerfaces. 2010 Sep 1;79(2):467-79. doi: 10.1016/j.colsurfb.2010.05.016. Colloids Surf B Biointerfaces. 2010. PMID: 20627665

5

Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.

Sosnik A, Seremeta KP, Imperiale JC, Chiappetta DA. Sosnik A, et al. Expert Opin Drug Deliv. 2012 Mar;9(3):303-23. doi: 10.1517/17425247.2012.655268. Epub 2012 Jan 19. Expert Opin Drug Deliv. 2012. PMID: 22257003 Review.

6

Nanomedicines in the future of pediatric therapy.

Sosnik A, Carcaboso AM. Sosnik A, et al. Adv Drug Deliv Rev. 2014 Jun;73:140-61. doi: 10.1016/j.addr.2014.05.004. Epub 2014 May 10. Adv Drug Deliv Rev. 2014. PMID: 24819219 Review.

7

Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance.

Chiappetta DA, Carcaboso AM, Bregni C, Rubio M, Bramuglia G, Sosnik A. Chiappetta DA, et al. Among authors: sosnik a. AAPS PharmSciTech. 2009;10(1):1-6. doi: 10.1208/s12249-008-9168-z. Epub 2009 Jan 6. AAPS PharmSciTech. 2009. PMID: 19127436 Free PMC article. Clinical Trial.

8

Episcleral implants for topotecan delivery to the posterior segment of the eye.

Carcaboso AM, Chiappetta DA, Opezzo JA, Höcht C, Fandiño AC, Croxatto JO, Rubio MC, Sosnik A, Abramson DH, Bramuglia GF, Chantada GL. Carcaboso AM, et al. Among authors: sosnik a. Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2126-34. doi: 10.1167/iovs.09-4050. Epub 2009 Oct 15. Invest Ophthalmol Vis Sci. 2010. PMID: 19834044

9

Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability [corrected].

Chiappetta DA, Hocht C, Taira C, Sosnik A. Chiappetta DA, et al. Among authors: sosnik a. Nanomedicine (Lond). 2010 Jan;5(1):11-23. doi: 10.2217/nnm.09.90. Nanomedicine (Lond). 2010. PMID: 20025460

10

A highly concentrated and taste-improved aqueous formulation of efavirenz for a more appropriate pediatric management of the anti-HIV therapy.

Chiappetta DA, Hocht C, Sosnik A. Chiappetta DA, et al. Among authors: sosnik a. Curr HIV Res. 2010 Apr;8(3):223-31. doi: 10.2174/157016210791111142. Curr HIV Res. 2010. PMID: 20158456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters